Zheng Quan Zhi Xing·2025-08-28 00:12Group 1: Yinlun Co., Ltd. - The company has established a product system of 4+N around four major fields: data centers, energy storage, charging and swapping, and low-altitude aircraft [1] - In the data center sector, products include megawatt-level immersion cooling equipment and precision air conditioning + cooling towers, with a customer layout of 3+3+N and positive progress in project cooperation [1] - The low-altitude aircraft sector is seeing smooth development in drone supercharging and energy storage thermal management, with an increase in megawatt-level supercharging capacity for new energy heavy trucks [1] - The humanoid robot segment has formed a product system of 1+4+N, including one major system, four modules, and key components, with progress in product development based on major customer needs [1] - A joint venture has been established with partners to focus on the development of dexterous hands, collaborating with several universities [1] Group 2: Jingxin Pharmaceutical - The company is deepening the commercialization layout of Jingnuoning, adding over 400 hospital admissions, covering more than 1,500 hospitals, and achieving revenue of 55 million yuan [2] - The JX11502 capsule has completed Phase II clinical trials, and the application for the marketing of the cariprazine capsule has been submitted, while the LP(a) lowering drug is advancing in Phase I [2] - The sales expense ratio has decreased by 2.41 percentage points, with expectations for stable expense ratios [2] - As of July 31, 2025, the company has repurchased shares worth 610 million yuan, primarily for equity incentives [2] - Revenue from medical devices reached 349 million yuan, a year-on-year increase of 12.01%, while revenue from raw materials decreased by 9.59% to 453 million yuan due to downstream destocking [2]